Online analyses targeting the expression of KAT6A and KAT6B between tumor tissues and paired normal tissues demonstrated that KAT6A and KAT6B were aberrantly expressed in multiple types of cancer, like RCC, breast cancer, and AML, which exhibited the most significant differences in expression profiles [34]. The gene discussed is KAT6A; the disease is acute myeloid leukemia.